Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Opioid Use Disorder (OUD) Market Size Outlook: How Fast Will Revenue Grow Through 2030?
The market for Opioid Use Disorder (OUD) has experienced substantial expansion. Projections indicate a growth from $4.37 billion in 2025 to $4.89 billion in 2026, reflecting a compound annual growth rate of 11.8%. Factors contributing to its expansion during the preceding period include the widespread prescription of opioid analgesics, a rise in the incidence of persistent pain, restricted availability of initial addiction interventions, societal prejudices concerning addiction treatment, and the increasing accessibility of illegal opioids.
Anticipated to expand significantly in the coming years, the opioid use disorder (OUD) market is projected to reach a valuation of $7.82 billion by 2030, driven by a compound annual growth rate (CAGR) of 12.5%. This upward trajectory during the forecast period is bolstered by several key factors, including increased financial contributions from governments towards addiction treatment initiatives, a greater acceptance of medication-assisted treatment, the proliferation of virtual and telehealth services for addiction support, broader insurance coverage for OUD interventions, and a heightened emphasis on strategies aimed at prevention and harm reduction. Furthermore, prominent trends expected to shape the market include a growing embrace of medication-assisted treatment programs, the enhanced combination of behavioral therapy with pharmaceutical treatments, the wider establishment of community-based opioid treatment facilities, a surge in interest for long-acting injectable treatments for OUD, and a more pronounced focus on preventing relapse and supporting sustained recovery.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp
Opioid Use Disorder (OUD) Market Growth Drivers: What Factors Are Accelerating Expansion?
The increasing prevalence of opioid addiction is anticipated to fuel the expansion of the opioid use disorder (OUD) market. Opioid addiction, a condition marked by persistent and uncontrolled opioid consumption with detrimental health outcomes, stems from the euphoric and pain-relieving properties of these substances. Sustained use can result in the development of tolerance, necessitating increased dosages for the same effect, which may ultimately lead to opioid use disorder. Illustrating this trend, the Centers for Disease Control and Prevention reported that in 2023, there were 79,358 drug overdose deaths involving any opioid in the United States, translating to 23.7 deaths per 100,000 individuals. Consequently, the rising incidence of opioid addiction is a primary driver for the growth observed in the opioid use disorder (OUD) market.
Opioid Use Disorder (OUD) Market Segment Analysis And Revenue Opportunities
The opioid use disorder (oud) market covered in this report is segmented –
1) By Drug Type: Buprenorphine, Naltrexone, Methadone
2) By Route Of Administration: Oral, Parenteral
3) By Age Group: 19 To 40, 41 To 60, 61 And Over
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies
Subsegments:
1) By Buprenorphine: Suboxone, Buprenorphine Tablets, Buprenorphine Film
2) By Naltrexone: Naltrexone Tablets, Vivitrol
3) By Methadone: Methadone Tablets, Methadone Oral Solution
Opioid Use Disorder (OUD) Market Trends: What Is Shaping Future Industry Growth?
The leading businesses within the opioid use disorder (OUD) sector are concentrating their efforts on crafting novel treatments, specifically advanced extended-release buprenorphine formulations, in response to the escalating need for long-duration therapies that aid compliance, alleviate withdrawal phenomena, and enhance recovery achievements. These extended-release buprenorphine products ensure a continuous supply of medication across weekly or monthly periods, presenting superior ease of use and consistent therapeutic levels when contrasted with daily oral or sublingual methods that potentially elevate the likelihood of relapse. A notable development occurred in May 2023 when Brixadi (buprenorphine) extended-release injection received approval from the U.S. Food and Drug Administration, a federal entity in the United States, for the management of moderate to severe opioid use disorder (OUD). Brixadi is offered in two distinct administrations: a weekly injection suitable for individuals initiating treatment with a single dose of a transmucosal buprenorphine product or those currently on the medication, and a monthly option designated for patients already undergoing treatment.
Opioid Use Disorder (OUD) Market Leading Players Shaping Industry Direction
Major companies operating in the opioid use disorder (oud) market are Indivior Plc., Alkermes Inc., Braeburn Pharmaceuticals Inc., Titan Pharmaceuticals Inc., BioDelivery Sciences International Inc., Camurus AB, Orexo US Inc., Rhodes Pharmaceuticals L P, Mallinckrodt Pharmaceuticals, Hikma Pharmaceuticals Plc., Teva Pharmaceutical Industries Ltd., Viatris Inc., Mylan NV, Adapt Pharma Inc., Opiant Pharmaceuticals Inc., Dr Reddy’s Laboratories Ltd., Cipla Limited, Luye Pharma Group, Amneal Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Knight Therapeutics, BioCorRx Inc., Lannett Company Inc., Zydus Cadila, Apotex Inc., Intas Biopharmaceuticals, Glenmark Pharmaceuticals Ltd., InterveXion Therapeutics
Access The Complete Opioid Use Disorder (OUD) Market Report:
https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report
Opioid Use Disorder (OUD) Market Leading Geography: Which Region Generates The Most Revenue?
North Americawas the largest region in the opioid use disorder (OUD) market in 2025. The regions covered in the opioid use disorder (oud) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model